🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Quest Diagnostics Incorporated

DGX Healthcare
$244.88 $-1.57 (-0.64%)
Market Cap: $27.03 B
Gurus Holding
12
Popularity Rank
#226
% of Shares Held
3.37%
Net Activity (Q2 2026)
-$24.13 M

Guru Ownership Trend

Guru Analysis for Quest Diagnostics Incorporated (DGX)

Quest Diagnostics Incorporated (DGX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 12 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $909.72 M.

Top institutional holders include Jeremy Grantham and Chris Davis.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $24.13 M net outflow during the quarter.

Recent activity highlights First Eagle Investment who increased their stake by 153.5%. Conversely, Manning & Napier Group reduced exposure by 78.8%.

Key Holders

Top 5 by Value

$400.21 M
$329.78 M
$24.91 M
$12.92 M
$5.3 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$9.4 M
Total Buy Value
New Buys 1
Additions 4
-$33.52 M
Total Sell Value
Reductions 5
Sold Out 3

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
8
Net Buyers
5

FAQs for Quest Diagnostics Incorporated (DGX)

Major holders include Jeremy Grantham ($400.21 M), Chris Davis ($329.78 M), Joel Greenblatt ($24.91 M). According to the latest reported data, 12 tracked investment managers collectively hold approximately 3.71 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $24.13 M, with 5 managers increasing positions and 8 managers reducing holdings.

During the most recent reporting period, 5 managers trimmed their positions, while 3 fully exited DGX. The total reported sell value was $33.52 M.

Yes, 1 managers opened new positions in DGX, and 4 increased their existing holdings. The total reported buy value was $9.4 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.90% Add 0.3% 1,888,207 $400.21 M Q2 2026
1.42% Reduce -3.8% 1,555,612 $329.78 M Q2 2026
0.06% Reduce -10.1% 117,533 $24.91 M Q2 2026
0.00% Add 21.7% 61,196 $12.92 M Q2 2026
0.71% Reduce -1.7% 25,018 $5.3 M Q2 2026
0.01% New Buy 23,380 $4.96 M Q2 2026
0.02% Reduce -48.1% 17,375 $3.68 M Q2 2026
0.16% 8,700 $1.84 M Q2 2026
0.00% Add 153.5% 7,606 $1.61 M Q2 2026
0.00% Add 8.2% 3,756 $796,084 Q2 2026
0.01% Reduce -78.8% 3,663 $778,900 Q2 2026
0.01% 2,900 $614,655 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form